Evidence map›Paper›PMID 37587110›Full record

ArticleNPJ science of food2023

Comparison of the relative impacts of acute consumption of an inulin-enriched diet, milk kefir or a commercial probiotic product on the human gut microbiome and metabolome.

Liam H Walsh, Aaron M Walsh, Isabel Garcia-Perez, Fiona Crispie, Adele Costabile, Richard Ellis, Jim Finlayson, Laura A Finnegan, Marcus J Claesson, Elaine Holmes and 1 more

Abstract read
In one paragraph

Article in NPJ science of food, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Liam H WalshTeagasc Food Research Centre, Moorepark, Fermoy, Co, Cork, Ireland.
Aaron M WalshTeagasc Food Research Centre, Moorepark, Fermoy, Co, Cork, Ireland.
Isabel Garcia-PerezSection of Biomolecular Medicine, Division of Computational Systems Medicine, Imperial College London, London, UK.
Fiona CrispieTeagasc Food Research Centre, Moorepark, Fermoy, Co, Cork, Ireland.
Adele CostabileSchool of Life and Health Sciences, University of Roehampton London, London, UK.
Richard EllisSurveillance and Laboratory Services Department, APHA, Addlestone, UK.
Jim FinlaysonNHS Highland, Highland Clinical Research Facility, University of the Highlands & Islands, Centre for Health Science, Inverness, UK.
Laura A FinneganTeagasc Food Research Centre, Moorepark, Fermoy, Co, Cork, Ireland.
Marcus J ClaessonSchool of Microbiology Department, University College Cork, Co, Cork, Ireland.
Elaine HolmesSection of Biomolecular Medicine, Division of Computational Systems Medicine, Imperial College London, London, UK.
Paul D CotterTeagasc Food Research Centre, Moorepark, Fermoy, Co, Cork, Ireland. paul.cotter@teagasc.ie.ORCID http://orcid.org/0000-0002-5465-9068

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been established that the human gut microbiota is central to health, and, consequently, there has been a growing desire to positively modulate its composition and/or function through, for example, the use of fermented foods, prebiotics or probiotics. Here, we compare the relative impact of the daily consumption of an inulin-enriched diet (n = 10), a commercial probiotic-containing fermented milk product (FMP) (n = 10), or a traditional kefir FMP (n = 9), over a 28-day period on the gut microbiome and urine metabolome of healthy human adults. None of the treatments resulted in significant changes to clinical parameters or biomarkers tested. However, shotgun metagenomic analysis revealed that kefir consumption resulted in a significant change in taxonomy, in the form of an increased abundance of the sub-dominant FMP-associated species Lactococcus raffinolactis, which further corresponded to shifts in the urine metabolome. Overall, our results indicated that daily consumption of a single portion of kefir alone resulted in detectable changes to the gut microbiota and metabolome of consumers.

Identifiers

PMID37587110
PMCPMC10432396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.